These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11154840)

  • 21. Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).
    Babault N; Allali-Hassani A; Li F; Fan J; Yue A; Ju K; Liu F; Vedadi M; Liu J; Jin J
    J Med Chem; 2018 Feb; 61(4):1541-1551. PubMed ID: 29320176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression.
    Pozzi V; Mazzotta M; Lo Muzio L; Sartini D; Santarelli A; Renzi E; Rocchetti R; Tomasetti M; Ciavarella D; Emanuelli M
    Int J Immunopathol Pharmacol; 2011; 24(1):69-77. PubMed ID: 21496389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covalent inhibitors of nicotinamide N-methyltransferase (NNMT) provide evidence for target engagement challenges in situ.
    Lee HY; Suciu RM; Horning BD; Vinogradova EV; Ulanovskaya OA; Cravatt BF
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2682-2687. PubMed ID: 29731364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A direct correlation between nicotinamide N-methyltransferase activity and protein levels in human liver cytosol.
    Smith ML; Burnett D; Bennett P; Waring RH; Brown HM; Williams AC; Ramsden DB
    Biochim Biophys Acta; 1998 Nov; 1442(2-3):238-44. PubMed ID: 9804963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-Carbolinium cations, endogenous MPP+ analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease.
    Matsubara K; Kobayashi S; Kobayashi Y; Yamashita K; Koide H; Hatta M; Iwamoto K; Tanaka O; Kimura K
    Neurology; 1995 Dec; 45(12):2240-5. PubMed ID: 8848200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells.
    Xu J; Capezzone M; Xu X; Hershman JM
    Mol Endocrinol; 2005 Feb; 19(2):527-39. PubMed ID: 15486044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells.
    Xu J; Moatamed F; Caldwell JS; Walker JR; Kraiem Z; Taki K; Brent GA; Hershman JM
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4990-6. PubMed ID: 14557485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metabolic activation of azaheterocyclics induced dopaminergic toxicity: possible candidate neurotoxins underlying idiopathic Parkinson's disease].
    Matsubara K
    Nihon Hoigaku Zasshi; 1998 Oct; 52(5):301-5. PubMed ID: 10077975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.
    Salehi Z; Mashayekhi F
    J Clin Neurosci; 2009 Jan; 16(1):90-3. PubMed ID: 19017558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological Study on Association between Nicotinamide N-Methyltransferase Gene Polymorphisms and Hyperlipidemia.
    Zhu XJ; Lin YJ; Chen W; Wang YH; Qiu LQ; Cai CX; Xiong Q; Chen F; Chen LH; Zhou Q; Li JH
    Biomed Res Int; 2016; 2016():7521942. PubMed ID: 27999813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinamide metabolism regulates glioblastoma stem cell maintenance.
    Jung J; Kim LJ; Wang X; Wu Q; Sanvoranart T; Hubert CG; Prager BC; Wallace LC; Jin X; Mack SC; Rich JN
    JCI Insight; 2017 May; 2(10):. PubMed ID: 28515364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells.
    Xu J; Hershman JM
    Thyroid; 2006 Feb; 16(2):151-60. PubMed ID: 16676400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseases.
    Williams AC; Ramsden DB
    Med Hypotheses; 2005; 65(2):353-62. PubMed ID: 15922112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.
    Ganzetti G; Sartini D; Campanati A; Rubini C; Molinelli E; Brisigotti V; Cecati M; Pozzi V; Campagna R; Offidani A; Emanuelli M
    Melanoma Res; 2018 Apr; 28(2):82-88. PubMed ID: 29420365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients.
    Molina JA; Benito-León J; Jiménez-Jiménez FJ; Ortí-Pareja M; Berbel A; Tallón-Barranco A; de Bustos F; Hernánz A
    Neurosci Lett; 1997 Dec; 238(3):139-41. PubMed ID: 9464639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease.
    Maruyama W; Abe T; Tohgi H; Naoi M
    Neurosci Lett; 1999 Feb; 262(1):13-6. PubMed ID: 10076861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
    Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
    Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.
    Kannt A; Pfenninger A; Teichert L; Tönjes A; Dietrich A; Schön MR; Klöting N; Blüher M
    Diabetologia; 2015 Apr; 58(4):799-808. PubMed ID: 25596852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Nicotinamide N-Methyltransferase in Dorsal Striatum in Cocaine Place Preference.
    Luo L; Shang FF; Long H; Jiang L; Zhu R; Zhao Q; Gu H; Kong J; Xu W; Zhao Y; Cen X
    Neuropsychopharmacology; 2017 Nov; 42(12):2333-2343. PubMed ID: 28726800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.
    Lewitt PA; Li J; Lu M; Beach TG; Adler CH; Guo L;
    Mov Disord; 2013 Oct; 28(12):1653-60. PubMed ID: 23873789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.